Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer

Published:2022-01-24 Issue:2 Volume:45 Page:61-65
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Park Joo-Hwan,Yeo Ja Hyun,Kim Young Saing,Park Inkeun,Ahn Hee Kyung,Cho Eun Kyung,Shin Dong Bok,Yang Jun-Young,Kim Hyung-Sik,Lee Woon Kee,Sym Sun Jin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference12 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer;Pyrhonen;Br J Cancer,1995

3. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial;Kang;Ann Oncol,2009

4. The role of overexpressed HER2 in transformation;Neve;Ann Oncol,2001

5. HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer;Van Cutsem;Gastric Cancer,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER-2 positive gastric cancer: Current targeted treatments;International Journal of Biological Macromolecules;2024-08

2. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study;Expert Opinion on Biological Therapy;2024-04-02

3. Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer;International Journal of Molecular Sciences;2024-04-01

4. An evaluation of the utilisation of biosimilar monoclonal antibody drugs in Ireland and barriers to their usage;Irish Journal of Medical Science (1971 -);2024-01-09

5. Biosimilars in Gastric Cancer;Biosimilars for Cancer Treatment;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3